DOXORUBICIN HYDROCHLORIDE

DOXORUBICIN HYDROCHLORIDE INTRAVENOUS HUMAN PRESCRIPTION DRUG

DOXORUBICIN HYDROCHLORIDE is an FDA drug label for the active ingredient DOXORUBICIN HYDROCHLORIDE manufactured by Zydus Lifesciences Limited administered by INTRAVENOUS. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20221101.

Generic name
DOXORUBICIN HYDROCHLORIDE
Manufacturer
Zydus Lifesciences Limited
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Dosage form
N/A
NDC
49315-008
Application
ANDA212299
Label effective
20221101

Indications & Usage

Not available.

Dosage & Administration

Not available.

Contraindications

Not available.

Warnings

Not available.

Adverse Reactions

Not available.

More products with the same ingredient

DOXORUBICIN HYDROCHLORIDE

DOXIL

Baxter Healthcare Company View label

DOXOrubicin Hydrochloride

Sun Pharmaceutical Industries, Inc. View label

Doxorubicin Hydrochloride

Mylan Institutional LLC View label

doxorubicin hydrochloride, Liposomal

Baxter Healthcare Corporation View label